We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Adverse Event Reporting Delays During Pandemics Must Be Explained
Adverse Event Reporting Delays During Pandemics Must Be Explained
March 2, 2012
Drugmakers unable to report timely postmarket adverse events during a flu outbreak should notify the FDA and have documents ready explaining the reasons for the delays, the agency says.